| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addressing the global cirrhosis epidemic: one size will not fit all
|
Wang, Peter L
|
|
|
5 |
3 |
p. 230-231
|
article
|
| 2 |
Alcohol and health: time for an overdue conversation
|
The Lancet Gastroenterology & Hepatology,
|
|
|
5 |
3 |
p. 229
|
article
|
| 3 |
Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study
|
Waljee, Akbar K
|
|
|
5 |
3 |
p. 276-284
|
article
|
| 4 |
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study
|
Chen, Ying-Xuan
|
|
|
5 |
3 |
p. 267-275
|
article
|
| 5 |
Biological therapy and recurrent cancer: a threat no more?
|
Limketkai, Berkeley N
|
|
|
5 |
3 |
p. 233-234
|
article
|
| 6 |
Charging forward in locally advanced pancreatic cancer
|
Segar, Jennifer
|
|
|
5 |
3 |
p. 234-236
|
article
|
| 7 |
Correction to Lancet Gastroenterol Hepatol 2019; 4: 934–47
|
|
|
|
5 |
3 |
p. e2
|
article
|
| 8 |
Correction to Lancet Gastroenterol Hepatol 2019; 4: 913–33
|
|
|
|
5 |
3 |
p. e2
|
article
|
| 9 |
Correction to Lancet Gastroenterol Hepatol 2020; 5: 42–54
|
|
|
|
5 |
3 |
p. e2
|
article
|
| 10 |
Correction to Lancet Gastroenterol Hepatol 2020; 5: 167–228
|
|
|
|
5 |
3 |
p. e2
|
article
|
| 11 |
Current and potential treatments for primary biliary cholangitis
|
Shah, Raj A
|
|
|
5 |
3 |
p. 306-315
|
article
|
| 12 |
Extracting the benefits of berberine for colorectal cancer
|
Kwon, Sohee
|
|
|
5 |
3 |
p. 231-233
|
article
|
| 13 |
Fatty liver disease: putting the spotlight on a silent menace for young adults
|
Bugianesi, Elisabetta
|
|
|
5 |
3 |
p. 236-238
|
article
|
| 14 |
Global disparities in faecal microbiota transplantation research
|
Olesen, Scott W
|
|
|
5 |
3 |
p. 241
|
article
|
| 15 |
Hepatitis D virus in Uzbekistan
|
Khodjaeva, Malika
|
|
|
5 |
3 |
p. 238-240
|
article
|
| 16 |
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
|
Philip, Philip A
|
|
|
5 |
3 |
p. 285-294
|
article
|
| 17 |
New advances in the treatment of paediatric functional abdominal pain disorders
|
Santucci, Neha R
|
|
|
5 |
3 |
p. 316-328
|
article
|
| 18 |
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study
|
Abeysekera, Kushala W M
|
|
|
5 |
3 |
p. 295-305
|
article
|
| 19 |
Psychedelics for alcohol use disorder: state of the research
|
Burki, Talha Khan
|
|
|
5 |
3 |
p. 243-244
|
article
|
| 20 |
Research in brief
|
Baker, Holly
|
|
|
5 |
3 |
p. 242
|
article
|
| 21 |
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|
|
|
|
5 |
3 |
p. 245-266
|
article
|
Journal description